Related Experiment Video
Updated: Jul 17, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
[C-reactive protein in cardiovascular diseases]
Wojciech Lubas1, Krzysztof Gutkowski
1Oddział Chorób Wewnetrznych, z Pododdziałem Intensywnej, Opieki Kardiologicznej Szpitala Ministerstwa, Spraw Wewnqtrznych i Administracji, w Rzeszowie. intmsw@mp.pl
Insights
Many heart attacks and strokes occur in people with normal cholesterol. High-sensitivity C-reactive protein (hs-CRP) testing may help identify cardiovascular disease risk beyond cholesterol levels.
Area of Science:
- Cardiology
- Biochemistry
- Inflammation Research
Context:
- Cardiovascular diseases (CVDs) pose a significant health burden.
- Elevated LDL-cholesterol is a known risk factor, but many CVD events occur in individuals with normal levels.
- This highlights the need for additional risk assessment markers.
Purpose:
- To review current knowledge on the association between C-reactive protein (CRP) and cardiovascular diseases.
- To emphasize the role of inflammation in atherogenesis.
- To explore the utility of CRP as a biomarker for CVD risk stratification.
Summary:
- C-reactive protein (CRP) is an acute-phase protein produced by the liver in response to inflammation.
- Traditionally used for inflammatory and neoplastic diseases, CRP measurement is increasingly recognized for its role in CVD.
- High-sensitivity CRP (hs-CRP) assays enable precise assessment of the link between inflammation, atherogenesis, and CVD complications.
Impact:
- CRP measurement, particularly hs-CRP, offers a valuable tool for identifying individuals at high risk for cardiovascular events.
- Integrating CRP into risk assessment protocols can improve patient management and preventative strategies.
- This review provides a foundation for understanding CRP's clinical significance in cardiology.
Abstract:
The half of all hart attacks and strokes occurred among persons without elevated LDL- cholesterol concentration. This statment indicates a necessity for consideration of additional factors allowed for identification of patients with high risk of cardiovascular diseases, other than high cholesterol level. The precise determination of inflammation in the atherogenesis process paid attention to biological inflammatory markers as indicators of development and course of atheromatosis related diseases. C-reactive protein ranked as an acute phase protein, produced by the liver as an answer to cytokine stimulation is an acknowledged inflammatory marker. The measurement of CRP concentration is traditionally used to establish diagnosis and course as a monitor of inflammatory and neoplastic diseases. The last few years brought a lot of data that suggested usefulness of CRP concentration measurements in cardiovascular diseases. Putting into diagnostics the measurement of CRP as a high sensitivity CRP method allowed to precisely determining the connection between atherogenesis process development and its complications. The aim of this paper is presentation of current knowledge concerning connection between CRP and cardiovascular diseases.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease IV: Nursing Management
